Had troubles in the 2000's, not only from the competition standpoint, but also from higher feedstock levels. Has been in this trading range for the last few years.
Other car stocks have capitulated much more than that is on the anticipation that if the economy slows down and car companies will get hurt most. Getting acquired. Entry point would be around a $10 range.
Stock has done absolutely nothing for the last 5 to 7 years. Valuation is somewhere between $85 and $100. Acquisition of Pfizer’s (PFE-N) consumer products division has been adding good value to the company's earnings quality. A good anchor to a portfolio.